Published in Probl Tuberk on January 01, 1999
Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. JAMA (2000) 8.42
Tuberculosis trends in eastern Europe and the former USSR. Tuber Lung Dis (1994) 1.81
[New microbiological Techniques in diagnosis of tuberculosis]. Probl Tuberk (1996) 1.13
[L-transformation of the mycobacterial population in the process of treating patients with newly detected destructive pulmonary tuberculosis]. Probl Tuberk (1980) 0.87
[Artificial pneumoperitoneum in the complex treatment of pulmonary tuberculosis patients isolating drug-resistant mycobacterium tuberculosis]. Probl Tuberk Bolezn Legk (2006) 0.85
[Distribution of HLA antigens in patients with tuberculosis]. Ter Arkh (1981) 0.82
Cost-effectiveness analysis of tuberculosis control policies in Ivanovo Oblast, Russian Federation. Ivanovo Tuberculosis Project Study Group. Bull World Health Organ (1998) 0.82
[Systemic transplantation of autologous mesenchymal stem cells of the bone marrow in the treatment of patients with multidrug-resistant pulmonary tuberculosis]. Probl Tuberk Bolezn Legk (2008) 0.79
[Molecular characteristics of multiresistant clinical strains of Mycobacterium tuberculosis isolated in Russia]. Mol Gen Mikrobiol Virusol (2000) 0.79
[New-onset pulmonary tuberculosis patients with schizophrenia: course and efficiency of treatment]. Probl Tuberk Bolezn Legk (2008) 0.79
Filtrable forms of mycobacteria tuberculosis. Z Erkr Atmungsorgane (1984) 0.79
[The correction of energy metabolism disorders in hypoxia by using vitamin K]. Eksp Klin Farmakol (1993) 0.78
[Alcoholism and pulmonary tuberculosis]. Vestn Akad Med Nauk SSSR (1989) 0.77
[Hypoxia and ethanol: the comparative aspects of a study]. Izv Akad Nauk Ser Biol (1994) 0.77
[Model of destructive tuberculosis in guinea pigs]. Biull Eksp Biol Med (1981) 0.77
[Significance of the L transformation and reversion of the causative agent in the epidemiology of tuberculosis]. Zh Mikrobiol Epidemiol Immunobiol (1984) 0.77
[Inhibition of the transplacental blastomogenic effect of N-nitrosomethylurea in rats by buformin]. Biull Eksp Biol Med (1980) 0.76
[Effectiveness of antitubercular chemotherapy combined with corticosteroids and immunomodulators]. Probl Tuberk (1990) 0.76
[Clinical and laboratory evaluation of the efficiency of chronic hemodialysis treatment using acidosuccinate in patients with terminal renal failure]. Ter Arkh (2013) 0.76
[Efficiency of a new standard chemotherapy regimen in the treatment of patients with recurrent pulmonary tuberculosis]. Probl Tuberk Bolezn Legk (2006) 0.76
[The effect of an epiphyseal extract on regulation of fat-carbohydrate metabolism]. Probl Endokrinol (Mosk) (1976) 0.76
[Quality of life and cognitive functions in patients with end-stage renal failure on hemodialysis using a succinate-containing dialyzing solution]. Ter Arkh (2014) 0.75
Effects of chemotherapy on the immunological characteristics of patients with primary destructive pulmonary tuberculosis. Bull World Health Organ (1984) 0.75
[Effectiveness of extracorporeal ultraviolet blood irradiation in treatment of chronic obstructive bronchitis in pulmonary tuberculosis]. Probl Tuberk (1998) 0.75
[Diagnosis of exogenous allergic alveolitis]. Probl Tuberk (1983) 0.75
[The clinical importance of the primary drug resistance of Mycobacterium tuberculosis in destructive forms of pulmonary tuberculosis]. Probl Tuberk (1972) 0.75
[Proteolytic and antiproteolytic potential of the sputum in chronic bronchitis patients during exacerbation]. Ter Arkh (1983) 0.75
[Tasks of the research institutes and the Chairs of tuberculosis in various USSR republics regarding the problem of chemotherapy of tuberculosis]. Probl Tuberk (1978) 0.75
[Scientific-technical progress and the practice of phthisiatry]. Probl Tuberk (1986) 0.75
[The clinical importance of the drug resistance of Mycobacterium tuberculosis in the practice of controlling tuberculosis (a review of WHO data and of foreign leterature)]. Probl Tuberk (1968) 0.75
[Differential diagnosis of intrathoracic adenopathies and pulmonary dissemination of different etiology]. Ter Arkh (1978) 0.75
[Clinical x-ray diagnosis of congenital lung development defects of the disseminated type in adults]. Ter Arkh (1984) 0.75
[Development and improvement of work in antituberculous dispensaries]. Sov Med (1977) 0.75
[Opportunities for the evaluation of the secondary reaction of antituberculosis drugs by several indicators, determined in the blood of patients with tuberculosis of the lungs]. Vopr Med Khim (1983) 0.75
[Morphologic and biochemical changes in Mycobacterium tuberculosis during chemotherapy]. Probl Tuberk (1983) 0.75
[HLA typing in extrinsic allergic alveolitis]. Z Erkr Atmungsorgane (1987) 0.75
[Diagnostic importance of the quantitative determination of the extent of bacteria excretion during the chemotherapy process in chronic destructive pulmonary tuberculosis]. Probl Tuberk (1981) 0.75
[An experimental study of the chemotherapeutic efficacy of flurenizid, a new antitubercular pharmaceutical]. Probl Tuberk (1990) 0.75
[Role of hereditary factors in pulmonary pathology]. Vestn Akad Med Nauk SSSR (1986) 0.75
[Isolation and study of the morphological properties and immunogenicity of filterable forms of Mycobacterium tuberculosis]. Zh Mikrobiol Epidemiol Immunobiol (1983) 0.75
[Side effects of antitubercular agents and current methods of detection of drug allergy in chemotherapy of tuberculosis]. Probl Tuberk (1976) 0.75
[Express method of determining the drug sensitivity of Mycobacterium tuberculosis using a liquid culture medium and a rotating thermostat]. Probl Tuberk (1982) 0.75
[Value of certain biochemical indices in differential diagnosis of allergic and toxic reactions to antibacterial preparations in patients with tuberculosis]. Sov Med (1970) 0.75
[Cavern morphology and the dynamics of the bacterial population in different variants of an experimental model of cavernous pulmonary tuberculosis]. Probl Tuberk (1982) 0.75
[A comparative evaluation of the results of classical x-ray study and computed tomography in patients with exogenous allergic alveolitis]. Vestn Rentgenol Radiol (1989) 0.75
[Double independent evaluation of roentgenograms and tomograms in patients with cavitation of the lungs]. Probl Tuberk (1975) 0.75
[Current problems in the diagnosis and treatment of tuberculosis]. Sov Med (1983) 0.75
The efficiency of chemotherapy with immunomodulators for patients with destructive lung tuberculosis. Z Erkr Atmungsorgane (1986) 0.75
[Clinical manifestations of extrinsic allergic alveolitis--a disease of tobacco growers]. Klin Med (Mosk) (1989) 0.75
[Vision disorders during the treatment of pulmonary tuberculosis with ethambutol]. Klin Med (Mosk) (1979) 0.75
[Glycolysis components and carbohydrate metabolic enzyme activity of the blood under long-term action of rifampicin and isoniazid]. Biull Eksp Biol Med (1982) 0.75
[The results of bacteriologic research on the bronchoalveolar lavage fluid and blood plasma in patients with sarcoidosis]. Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol (1989) 0.75
[The 40th anniversary of the World Health Organization]. Probl Tuberk (1988) 0.75
[Diagnostic indicators in exogenous allergic alveolitis (poultry farmers' disease)]. Sov Med (1984) 0.75
[Collective study of atypical Mycobacteria]. Probl Tuberk (1981) 0.75
[Principal results of the scientific study of the tuberculosis problem of in 1974]. Probl Tuberk (1975) 0.75
[Clinical value of diagnostic bronchoalveolar lavage in diffuse diseases of the lungs]. Probl Tuberk (1987) 0.75
[Use of lyophilized Löwenstein-Jensen culture medium for determining drug resistance of Mycobacterium tuberculosis]. Lab Delo (1986) 0.75
[Methods in the modern chemotherapy of tuberculosis (a lecture)]. Probl Tuberk (1988) 0.75
[Relation between the dynamics of immunologic indices and newly detected pulmonary tuberculosis patients and the timing of the end of bacterial isolation and the closure of destruction cavities]. Probl Tuberk (1982) 0.75
[Hemosorption and extracorporeal membrane oxygenation of the blood in the therapy of patients with chronic lung diseases]. Probl Tuberk (1986) 0.75
[Current goals of sanatorial treatment of patients with tuberculosis]. Probl Tuberk (1978) 0.75
[Exogenous allergic alveolitis]. Sov Med (1982) 0.75
Role of broncho-alveolar lavage in the diagnosis of pulmonary disease. Arch Monaldi Mal Torace (1989) 0.75
[Current identification of early and timely detection of patients with tuberculosis]. Probl Tuberk (1976) 0.75
[Effectiveness of the treatment of experimental destructive pulmonary tuberculosis with antibacterial drugs combined with levamisole and diucifon]. Probl Tuberk (1984) 0.75
[The role of broncho-alveolar lavage in the diagnosis of pulmonary diseases]. Plucne Bolesti (1988) 0.75
[60th anniversary of the founding of the USSR and tasks in the further development of phthisiology and pulmonology]. Probl Tuberk (1982) 0.75
[Experience in identifying exogenous allergic alveolitis]. Probl Tuberk (1983) 0.75
[Immunological status of newly detected patients with destructive pulmonary tuberculosis]. Probl Tuberk (1979) 0.75
[Means of increasing the effectiveness of the modern microbiological diagnosis of tuberculosis and nonspecific lung diseases]. Zh Mikrobiol Epidemiol Immunobiol (1983) 0.75
[Results and developmental outlook of research in the fields of phthisiology and pulmonology]. Vestn Akad Med Nauk SSSR (1987) 0.75
[Examination of the bronchoalveolar lavage fluid and blood plasma of patients with sarcoidosis]. Klin Med (Mosk) (1987) 0.75
[Differential x-ray diagnosis of disseminated tuberculosis and sarcoidosis of the lungs]. Probl Tuberk (1989) 0.75
[Bronchoalveolar lavage in patients with pulmonary tuberculosis]. Probl Tuberk (1984) 0.75
[Current theories on the pathogenesis of tuberculosis (lecture)]. Probl Tuberk (1988) 0.75
[Differential diagnosis of tuberculosis of the respiratory organs]. Probl Tuberk (1979) 0.75
[Activities of the All-Union Scientific Society of Phthisiologists during the period between congresses (1974-1979)]. Probl Tuberk (1979) 0.75
[Differential diagnosis of proctacted pneumonia and recurrent tuberculosis]. Klin Med (Mosk) (1976) 0.75
[Clinical variants of the course and the characteristics of the x-ray changes in extrinsic allergic alveolitis--tobacco growers' disease]. Ter Arkh (1990) 0.75
[Immunological methods of examination in differential diagnosis of various lesions of the middle lobe and lingular segments of the lungs]. Ter Arkh (1978) 0.75
[Modifications in standard chemotherapy and the effectiveness of treatment in newly diagnosed patients with cavitary forms of tuberculosis]. Probl Tuberk (1972) 0.75
[Diagnosis and treatment of fibrosing alveolitis]. Ter Arkh (1987) 0.75
[Diagnosis of pulmonary hemosiderosis]. Ter Arkh (1978) 0.75
[Basic trends in the development of chemotherapy of tuberculosis]. Probl Tuberk (1975) 0.75
[Collective experience with bacteriophage typing and identification of Mycobacterium tuberculosis isolated in the USSR and CSSR]. Probl Tuberk (1987) 0.75
[Clinical significance of the diagnostic broncho-alveolar lavage]. Ter Arkh (1983) 0.75
[Rifampicin in the treatment of newly detected destructive pulmonary tuberculosis]. Probl Tuberk (1978) 0.75
[Classification of sarcoidosis]. Probl Tuberk (1982) 0.75
[Sarcoidosis of the respiratory organs (diagnosis and treatment)]. Klin Med (Mosk) (1983) 0.75
[Clinical picture and diagnosis of rare lung diseases]. Ter Arkh (1979) 0.75
[Modern concepts of the structure of Mycobacterium tuberculosis]. Zh Mikrobiol Epidemiol Immunobiol (1982) 0.75
[The etiologic significance of ultrafine forms of the causative agent of tuberculosis in the development of sarcoidosis of the respiratory organs]. Probl Tuberk (1989) 0.75
[X-ray diagnosis of histiocytosis X]. Ter Arkh (1988) 0.75
[Phthisiology as a medical and scientific specialty]. Probl Tuberk (1990) 0.75
[Characteristics of morphological changes in the lungs of guinea pigs after administration of ultra-small forms of Mycobacteria obtained from patients with tuberculosis]. Probl Tuberk (1986) 0.75